There is so much more to be said about this. We can debate all night about it. I am sure there will come a time for this debate, where we can discuss all these matters. But, you know, I am concerned that we not lose this opportunity to help mankind. I remember in the early 1970s, mid-1970s, when recombinant DNA was so heavily lobbied against, the research, and it was another type of cloning research. It was not the same as this, it is not cloning a living mother's egg, but nevertheless, it involved cloning. Similar arguments were made against recombinant DNA research. I have to tell you that we went ahead anyway, the research was done, and today we have over 60 mainline drugs that came from recombinant DNA--cloning--research, not the least of which is human insulin which is saving millions of lives today in this world. In fact, virtually every major scientific breakthrough through history has had those who have argued against it. And there have been some which have not proven efficacious, such as fetal tissue research. I made the arguments on the floor against fetal tissue research at the time. So far, I believe that science has not been able to derive the projected benefits from fetal tissue research. I am not saying I was right; I am just saying the fact is, it did not prove as efficacious as originally thought.
Orrin Hatch: “There is so much more to be said about this. We can debate all night about it. I am sure there will come a time for this…”
Editor's note · Context
Discussing the importance of scientific research and past debates on cloning and recombinant DNA.
Share
More from Orrin Hatch
Those backlogs at the Social Security Administration are unacceptable to many, if not most, of us here in the Senate.
I intend to focus this morning on the investigation that was self-initiated by the Department of Commerce under section 232 of the Trade Expansion Act of 1962 to determine whether imports of automobiles and automotive parts threaten to…
I rise today to introduce the Traumatic Brain Injury Program Reauthorization Act of 2018. I want to thank my colleague, Senator Casey, for working with me once again on important legislation to reauthorize the Federal Traumatic Brain…
I wish to enter a few remarks into the Record regarding section 103(a) of the Music Modernization Act, which the Senate recently passed. By striking current sections 114(f)(1) and (2) of title 17 and substituting a new section 114(f)(1)…





